Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04666844 · ClinicalTrials.gov registry record
Predicting Transfers to Hemodialysis in Peritoneal Dialysis Patients Using the Surprise Question
A clinical trial, sponsored by Satellite Healthcare.
- Completed
- Registry status
- 2,019
- Enrollment target
NCT04666844: Completed study, sponsored by Satellite Healthcare.
NCT04666844 is a clinical trial that has completed, run by Satellite Healthcare. The registered enrollment target is 2,019 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04666844 has completed, sponsored by Satellite Healthcare.
- COMPLETED
- Registry status
- 2,019 participants
- Enrollment target
Study Summary
The investigators will assess the prediction performance of the modified Surprise Question (Will the participant be surprised if this patient transfers to hemodialysis in the next 6 months?) for identification of peritoneal dialysis at high risk of transfer to hemodialysis. The investigators will also assess the prediction performance of a modified mortality surprise question (Will the participant be surprised if this patient dies in the next 6 months?).
Interventions
- OTHER no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,019 participants |
| Start Date | 2020-11-20 |
| Est. Completion | 2022-07-20 |
What the finished NCT04666844 record still lists
NCT04666844 is an observational study that tracks outcomes without assigning an intervention. Its 2,019 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which no intervention is the first listed.
NCT04666844 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04666844 about?
NCT04666844 is a clinical study titled "Predicting Transfers to Hemodialysis in Peritoneal Dialysis Patients Using the Surprise Question". The investigators will assess the prediction performance of the modified Surprise Question (Will the participant be surprised if this patient transfers to hemodialysis in the next 6 months?) for identification of peritoneal dialysis at high risk of transfer to hemodialysis. The investigators will al...
What is the current status of trial NCT04666844?
This trial is currently completed. The enrollment target is 2,019 participants. The study started on 2020-11-20. Estimated completion is 2022-07-20.
What interventions are being tested in trial NCT04666844?
The interventions under investigation include: no intervention (OTHER).
Who is sponsoring clinical trial NCT04666844?
This trial is sponsored by Satellite Healthcare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI